Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 11 - 20 of about 188   

Articles published

AZN 4,705.50 -44.00 (-0.93%)
price chart
Earnings Preview: Juniper Networks, Inc., American Airlines Group Inc., and ...
Among the stocks gearing up to report earnings are tech concern Juniper Networks, Inc. (NYSE:JNPR), airline issue American Airlines Group Inc. (NASDAQ:AAL), and biotech firm AstraZeneca plc (ADR) (NYSE:AZN). Below, we'll take the pre-earnings ...
AstraZeneca plc (AZN) Posts Quarterly Earnings Results, Beats Estimates By ...
AstraZeneca plc logo AstraZeneca plc (NYSE:AZN) posted its quarterly earnings results on Friday. The company reported $1.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.01, Stock Ratings Network.
Why GlaxoSmithKline plc Beats AstraZeneca plc And Royal Dutch Shell Plc ...
Pharmaceuticals and Big Oil are great sectors for the kind of long-term investment that ISAs are perfect for. It's generally better to put the tax-wrapper of an ISA around funds that you plan to leave to grow the longest.
AstraZeneca plc Stock Rating Reaffirmed by Berenberg Bank (AZN)
AstraZeneca plc logo AstraZeneca plc (LON:AZN)'s stock had its �hold� rating reiterated by analysts at Berenberg Bank in a research report issued to clients and investors on Friday.
AstraZeneca plc's "Buy" Rating Reiterated at Jefferies Group (AZN)  Mideast Time
Arrow Global Group PLC Price Target Increased to GBX 362 by Analysts at ...  WKRB News
GlaxoSmithKline plc vs AstraZeneca plc: Which Pharmaceutical Major Should ...
Since the turn of the year, GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has easily outperformed AstraZeneca (LSE: AZN) (NYSE: AZN.
Zacks Reiterates Hold Rating for AstraZeneca plc (AZN)  Dakota Financial News
AstraZeneca plc 18.9% Potential upside - 'BUY' Rating reiterated
AstraZeneca plc with EPIC LON:AZN had its stock rating noted as 'Reiterates' with the recommendation being set at 'BUY' this morning by analysts at Liberum Capital.
AstraZeneca plc Earns Hold Rating from Deutsche Bank (AZN)  The Legacy
Barclays Reaffirms "Underweight" Rating for AstraZeneca plc (AZN)  Dakota Financial News
3 Troubled Stocks Poised To Snap Back: AstraZeneca plc, Rolls-Royce Holding ...
Exclusivity losses on such products as Symbicort and Seroquel has smashed revenues in recent years, and in February a US court found that the patent for its Pulmicort Respules was invalid, adding to the company's existing headaches -- AstraZeneca was ...
Will AstraZeneca plc (ADR) Disappoint Investors?
Currently, there is market speculation about whether AstraZeneca plc (ADR) (NYSE:AZN) can reach its 2023 sales target of $45 billion amid a massive patent cliff faced by the company's older drugs and a promising new cancer drug pipeline.
AstraZeneca plc (ADR) Bags Two Wins For Cancer Drug Portfolio
AstraZeneca plc's (ADR) (NYSE:AZN) investigational lung cancer treatment postpones disease advancement by more than a year, as per a company analysis presented today at the European Lung Cancer Conference in Geneva.
AstraZeneca plc Earns "Neutral" Rating from JPMorgan Chase & Co. (AZN)
AstraZeneca plc (NYSE:AZN)'s stock had its �neutral� rating reiterated by equities researchers at JPMorgan Chase & Co.